We can’t feed our pets raw food until this bird flu’s properly managed, and preferably wiped TF out.
10 Likes
9 Likes
Glenmark issues another recall, this time for 1.5M bottles of ADHD drug due to impurities
Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another.
This time, the product pull covers about 1.48 million bottles of the generic attention-deficit/hyperactivity disorder (ADHD) drug atomoxetine.
Eli Lilly previously sold the branded version of the drug, Strattera, but discontinued all strengths in 2023 after the arrival of generics.
The recall was triggered by the presence of unacceptable levels of N-nitroso atomoxetine, a possible carcinogen, in multiple Glenmark atomoxetine batches, according to the FDA.
If this may affect you, check your generic manufacturer on the label. This manufacturer seems to have a either an incredibly run of bad luck or some serious quality control issues.
12 Likes
8 Likes